Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2002
09/24/2002US6455678 Human hematopoietic stem and progenitor cell antigen
09/24/2002US6455668 Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/24/2002US6455496 NL2 TIE ligand homologue polypeptide
09/24/2002US6455494 Use of p97 and iron binding proteins as diagnostic and therapeutic agents
09/24/2002US6455492 Hepatitis E virus vaccine and method
09/24/2002US6455325 Liquid processing method making use of pipette device and apparatus for same
09/24/2002US6455324 Embossed test strip system
09/24/2002US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus
09/24/2002US6455322 Competition binding assay for detecting P2YADP receptor ligands
09/24/2002US6455321 Method for interpreting tandem mass spectrometry data for clinical diagnosis
09/24/2002US6455319 Use of spatiotemporal response behavior in sensor arrays to detect analytes in fluids
09/24/2002US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents
09/24/2002US6455303 Apparatus for detection/drug screening of receptor or ion channel modulators using patch-clamp and capillary electrophoresis
09/24/2002US6455292 Polypeptide which codes for kinase of defined amino acid sequence; for treatment of brain and pancreatic diseases
09/24/2002US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/24/2002US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same
09/24/2002US6455288 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
09/24/2002US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents
09/24/2002US6455281 Nucleic acids for identifying anti-fungal agents, and uses related thereto
09/24/2002US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics
09/24/2002US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
09/24/2002US6455268 Hydrolytic enzyme substrates and assay method
09/24/2002US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases
09/24/2002US6455266 Receptor for a Bacillus thuringiensis toxin
09/24/2002US6455263 Fluorescent labeling; binding to target moleculaes
09/24/2002US6455261 Diagnostic assay using microperoxidase
09/24/2002US6455260 Monitorng preferential particles in sample; provide opaque glass support, incubate with sample, illuminate surface with light, monitor fluorescent emission, emission indicates presence of preferential particle in sample
09/24/2002US6455255 Using selectively primed adaptive driver-representational difference analysis
09/24/2002US6455254 Nucleotide sequence profile of sample; obtain nucleotide sequences, determine nucleotide sequence, screen library, determine nucleotide sequence profile
09/24/2002US6455253 Methods and compositions for polypeptide engineering
09/24/2002US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
09/24/2002US6455248 Reagents and kits for detecting fungal pathogens in a biological sample
09/24/2002US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes
09/24/2002US6455246 Human xenografts for microbicide testing and anatomical modeling
09/24/2002US6455245 For immunoassay detection
09/24/2002US6455243 Detecting malnutrition in mammals by measuring activity of mitochondrial enzyme complex in a sample and comparing to control where decreased activity indicates reduced nutrition
09/24/2002US6455044 5c8 antigen
09/24/2002US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin
09/24/2002US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene
09/24/2002US6455007 Testing fabric care products; sheet having porous test regions interposed between plates
09/24/2002US6455001 Wetting agents are fatty acid amides n-substituted with alkylcarboxylates or alkylsulfonates
09/24/2002US6454947 Liquid chromatography, flow injection analysis for nonbiological combinatorial polymer libraries; discovery of commercially important polymers, polymerization conditions; near-real-time industrial process control
09/24/2002US6454924 Microfluidic devices and methods
09/24/2002US6454726 Monitoring method
09/24/2002US6454459 Device and process for thermal analysis of molten metals
09/24/2002US6454141 Non-pressurized dry powder dispensing apparatus
09/24/2002US6453726 Gas sensor with U-type gasket
09/24/2002US6453723 Gas sensor device
09/24/2002US6453663 NOx sensor monitoring
09/24/2002CA2096250C Assay for glycated blood proteins
09/24/2002CA2096223C Treatment for tissue ulceration
09/24/2002CA2065325C Cdr grafted anti-cea antibodies and their production
09/24/2002CA2063273C Surfactant compositions and methods
09/22/2002CA2368664A1 Method for accelerated aging of neat asphalt binder using microwave radiation process
09/22/2002CA2342085A1 Sterol glucoside toxins
09/20/2002CA2377213A1 Method for providing clinical diagnostic services
09/19/2002WO2002073711A1 Multi-color organic display with light-emitting layers formed by flexographic pinting
09/19/2002WO2002073605A2 Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
09/19/2002WO2002073504A1 A system and method for retrieving and using gene expression data from multiple sources
09/19/2002WO2002073373A2 Ensemble-based strategy for the design of protein pharmaceuticals
09/19/2002WO2002073228A2 Method for high resolution magnetic resonance analysis using magic angle technique
09/19/2002WO2002073214A2 Novel reagents for detecting cannabinoids
09/19/2002WO2002073213A2 Assay
09/19/2002WO2002073212A2 Diagnostic screens for alzheimer's disease
09/19/2002WO2002073211A1 Method for screening a dna expression base
09/19/2002WO2002073210A1 Method for promoting aggregate formation from protein subunits
09/19/2002WO2002073209A2 Method for identifying immune reactive epitopes on proteins
09/19/2002WO2002073208A2 Anti-epileptogenic agents
09/19/2002WO2002073207A2 Isolated ductal fluid sample
09/19/2002WO2002073206A2 Metabolic phenotyping in therapy with anxiolytics
09/19/2002WO2002073205A2 Metabolic phenotyping in therapy with immunosuppressants
09/19/2002WO2002073204A2 Cell-based detection and differentiation of disease states
09/19/2002WO2002073203A1 Method of measuring whole blood
09/19/2002WO2002073202A1 Phycoerythrin labeled thyronine analogues and assays using the labeled analogues
09/19/2002WO2002073201A1 Reagents for labeling protein
09/19/2002WO2002073200A1 Methods to increase the capacity of high content cell-based screening assays
09/19/2002WO2002073199A1 Automated methods of detecting receptor activity
09/19/2002WO2002073198A2 Non-separation assay and system using opaque particles
09/19/2002WO2002073197A2 Individualization of therapy with antidepressants
09/19/2002WO2002073196A2 Individualization of therapy with antipsychotics
09/19/2002WO2002073195A2 Diagnostic of metal allergy through cytokine release by t-cells in vitro
09/19/2002WO2002073193A1 Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis
09/19/2002WO2002073192A1 A crystal of bacterial core rna polymerase with rifampicin and methods of use thereof
09/19/2002WO2002073190A1 Method of sorting particulates with different specific gravities
09/19/2002WO2002073189A2 Method and apparatus for on-line monitoring of quality and/or condition of highly resistive fluids
09/19/2002WO2002073183A1 Electrochemical detection method of complementarity to nucleic acid bases
09/19/2002WO2002073180A1 An antibody-based protein array system
09/19/2002WO2002073179A1 Apparatus and method for analysing fluids
09/19/2002WO2002073176A2 Sensor for detecting gas
09/19/2002WO2002073172A2 Determination of analytes by means of fluorescence correlation spectroscopy
09/19/2002WO2002073158A2 Conjugate probes and optical detection of analytes
09/19/2002WO2002073157A2 Direct detection of biomolecules in polyacrylamide gel
09/19/2002WO2002073155A1 Ultrasensitive non-isotopic water-soluble nanocrystals
09/19/2002WO2002073154A2 Method and the detection of bacteria and bacterial groups
09/19/2002WO2002073153A2 Module for an analysis device, applicator as an exchange part of the analysis device and analysis device associated therewith
09/19/2002WO2002072892A1 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
09/19/2002WO2002072887A2 Immobilisation of ligands using saccharides
09/19/2002WO2002072886A2 Complex element micro-array and methods of use
09/19/2002WO2002072884A1 DETECTING BINDING OF mRNA TO AN OLIGONUCLEOTIDE ARRAY USING RNA DEPENDENT NUCLEIC ACID MODIFYING ENZYMES
09/19/2002WO2002072881A2 Method for the amplification and detection of hbv dna using a transcription based amplification